angiotensin ii has been researched along with Angiitis in 64 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.56) | 18.2507 |
| 2000's | 32 (50.00) | 29.6817 |
| 2010's | 30 (46.88) | 24.3611 |
| 2020's | 1 (1.56) | 2.80 |
| Authors | Studies |
|---|---|
| Finger, S; Garlapati, V; Karbach, SH; Knopp, T; Knorr, M; Kossmann, S; Lagrange, J; Molitor, M; Münzel, T; Nguyen, TS; Rudi, WS; Ruf, W; Schüler, R; Wenzel, P; Wild, J | 1 |
| Jang, HC; Kim, KM; Kong, SH; Lee, DH; Lee, JE; Lim, S; Min, SH; Oh, TJ; Park, KS | 1 |
| Aureille, J; Baron-Menguy, C; Carbone, ML; Castan, L; Chadeuf, G; Desfrançois, J; Durand, M; Goueffic, Y; Heurtebise-Chrétien, S; Loirand, G; Prieur, X; Quillard, T; Rio, M; Tesse, A; Torres, RM; Vaillant, N | 1 |
| Huang, M; Jia, W; Liu, X; Long, F; Qin, M; Su, Z; Suguro, R; Wu, W; Xiao, C; Yang, D; Zhu, Y | 1 |
| Ahmad, F; Leake, DS; Neumann, F; Palmer, C; Peri, F; Pirianov, G | 1 |
| Beisele, M; Daiber, A; Hausding, M; Jansen, T; Kerahrodi, JG; Kröller-Schön, S; Lackner, KJ; Münzel, T; Oelze, M; Schüler, A; Schulz, E; Wenzel, P | 1 |
| Bucciarelli, L; Colombo, PC; Demmer, RT; Harxhi, A; Hayashi, Y; Jelic, S; Jorde, UP; Kebschull, M; LeJemtel, TH; Onat, D; Papapanou, P; Sabbah, HN; Schmidt, AM; Uriel, N | 1 |
| Chen, W; Harrison, DG; Kirabo, A; Madhur, MS; Saleh, MA; Thabet, SR; Trott, DW; Wu, J; Xiao, L | 1 |
| Chen, HZ; Gao, P; Hao, DL; Li, L; Liu, DP; Lu, J; Xu, J; Xu, TT | 1 |
| He, C; Li, H; Viollet, B; Xie, Z; Zou, MH | 1 |
| Chalouhi, N; Chu, Y; Faraci, FM; Gu, H; Hasan, DM; Heistad, DD; Sigmund, CD; Starke, RM; Wilson, K | 1 |
| Chen, J; Cui, G; Diao, H; Ding, Y; Lu, C; Wang, L; Wei, Y | 1 |
| Budzyn, K; Drummond, G; Guzik, B; Guzik, TJ; Harrison, DG; Lob, HE; Marvar, PJ; Mikolajczyk, TP; Nosalski, R; Osmenda, G; Podolec, J; Sagan, A; Skiba, D; Szczepaniak, P; Vinh, A; Wu, J | 1 |
| Pantan, R; Suksamrarn, A; Tocharus, C; Tocharus, J | 1 |
| Kossmann, S; Lagrange, J; Wenzel, P | 1 |
| Marchesi, C; Paradis, P; Schiffrin, EL | 1 |
| Abe, J; Alexis, JD; Berk, BC; Che, W; Ding, B; Korshunov, VA; Lerner-Marmarosh, N; Sahni, A; Wang, N; Yan, C; Zou, Y | 1 |
| Fujita, T; Higaki, J; Horiuchi, M; Iwai, M; Iwanami, J; Min, LJ; Mogi, M; Nahmias, C; Okayama, H; Sakata, A; Tsukuda, K | 1 |
| Gou, W; Ji, Y; Liu, J; Liu, N; Wang, Z | 1 |
| Drummond, GR; Harrison, CB; Selemidis, S; Sobey, CG | 1 |
| Born, W; Brain, SD; Clark, N; Fischer, JA; Husmann, K; Keeble, J; Liang, L; Poston, R; Pozsgai, G; Shah, A; Siow, R; Tam, CW | 1 |
| Apostolakis, S; Krambovitis, E; Spandidos, DA; Vlata, Z; Vogiatzi, K | 1 |
| Loria, AS; Pollock, DM; Pollock, JS | 1 |
| Gordon, FJ; Guzik, TJ; Harrison, DG; Lob, HE; Marvar, PJ; McCann, LA; Thabet, SR; Weyand, C | 1 |
| Lazartigues, E | 1 |
| Kondo, M; Oettgen, P; Yuan, L; Zhan, Y | 1 |
| Chen, CC; Ferreri, NR | 1 |
| Berzins, B; Feather, D; Freund, B; Gong, Y; Landesberg, G; Mishra, G; Scalia, R | 1 |
| Becker, C; Daiber, A; Grabbe, S; Hausding, M; Jonuleit, H; Karbach, SH; Knorr, M; Kossmann, S; Münzel, T; Oelze, M; Schuhmacher, S; Schulz, E; Schwenk, M; Stratmann, J; Waisman, A; Wenzel, P; Yogev, N | 1 |
| Eagleton, MJ; Ehrman, B; Graham, LM; Xu, J | 1 |
| Arita, Y; Fujio, Y; Hashimoto, T; Higuchi, K; Ikeoka, K; Komuro, I; Kuroda, T; Minami, T; Mochizuki, N; Nakaoka, Y; Nishida, K; Shioyama, W; Shirai, M; Yamauchi-Takihara, K; Yasui, T | 1 |
| Brummer, T; Halbach, S; Wöhrle, FU | 1 |
| Feng, J; Hu, J; Huang, Y; Kong, W; Liu, B; Liu, Z; Luo, H; Ma, K; Wang, X; Xie, J; Xu, Q; Zhan, S; Zhang, L; Zheng, J; Zhu, Y | 1 |
| Chu, Y; Faraci, FM; Heistad, DD; Miller, JD; Mitchell, IJ; Peña Silva, RA; Penninger, JM | 1 |
| Briet, M; Schiffrin, EL | 1 |
| Du, J; Jia, L; Liu, O; Liu, X; Qin, Y; Wang, X; Wang, Y; Zhang, H | 1 |
| Delyani, J; Martin-Berger, CL; McMahon, E; Rocha, R; Scherrer, R; Yang, P | 1 |
| Jankowski, M; Liu, J; Pagano, PJ; Yang, F; Yang, XP | 1 |
| Schiffrin, EL; Touyz, RM | 1 |
| Dechend, R; Fiebeler, A; Luft, FC; Müller, DN; Park, JK | 1 |
| Cathcart, MK | 1 |
| Fujita, T; Goto, A; Hirata, Y; Nagai, R; Nishimatsu, H; Oba, S; Omata, M; Satonaka, H; Suzuki, E; Takeda, R | 1 |
| Anderson, K; Angermann, CE; Barone, FC; Behr, TM; Berova, M; Coatney, RW; Sackner-Bernstein, JD; Willette, RN | 1 |
| Bandinelli, M; Boddi, M; Cecioni, I; Chiavarelli, M; Coppo, M; Lisi, GF; Modesti, PA; Neri Serneri, GG; Papa, ML; Toscano, T | 1 |
| Saruta, T; Sato, A | 1 |
| Egashira, K; Hiasa, K; Ishibashi, M; Takeshita, A; Tan, C; Zhao, Q | 1 |
| Ergul, A; Fagan, SC; Hess, DC; Hohnadel, EJ; Pollock, DM | 1 |
| Aubert, JF; Bouzourene, K; Brunner, HR; Duchosal, MA; Gabbiani, G; Hao, H; Hayoz, D; Korber, M; Mazzolai, L; Nussberger, J; Vallet, V | 1 |
| Felmeden, D; Lim, HS; Lip, GY | 1 |
| da Cunha, V; Deng, G; Ho, JJ; Martin-McNulty, B; Rutledge, JC; Sullivan, ME; Tham, DM; Vergona, R; Wang, YX; Wilson, DW | 1 |
| Cheng, J; Du, J; Ma, Y; Zhang, J; Zhang, L | 1 |
| Amiri, F; Brassard, P; De Ciuceis, C; Endemann, DH; Schiffrin, EL; Touyz, RM | 1 |
| Imai, T; Katayama, S; Morita, T; Sugiyama, T; Yoshino, G | 1 |
| Clergue, M; Corda, S; Duriez, M; Levy, BI; Michel, F; Silvestre, JS; Verbeuren, T; Vilaine, JP; Waeckel, L | 1 |
| Bautista, R; Franco, M; Herrera-Acosta, J; Johnson, RJ; Martínez, F; Montoya, A; Nepomuceno, T; Rodríguez-Iturbe, B; Santamaría, J; Tapia, E | 1 |
| Egido, J; Esteban, V; Ruiz-Ortega, M | 1 |
| Savoia, C; Schiffrin, EL | 1 |
| Chen, MF; Li, YJ; Luo, BL; Wang, YJ; Xie, XM; Yang, TL; Zhang, XH | 1 |
| Hirata, Y; Kimura, K; Nagai, R; Nagano, T; Nishimatsu, H; Oba, S; Suzuki, E; Takahashi, M; Takeda, R | 1 |
| Hagl, S; Kranzhöfer, R; Kübler, W; Libby, P; Pfeiffer, CA; Schmidt, J | 1 |
| Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Mervaala, EM; Muller, DN; Park, JK; Schmidt, F; Theuer, J | 1 |
| Bush, E; Dawson, TC; DeLeon, H; Kuziel, WA; Maeda, N; Taylor, WR; Wilcox, JN | 1 |
| Boer, P; Braam, B; Gröne, H; Hohbach, J; Joles, JA; Koomans, HA; Verhagen, AM | 1 |
| Dechend, R; Fiebeler, A; Haller, H; Luft, FC; Müller, DN; Park, JK | 1 |
11 review(s) available for angiotensin ii and Angiitis
| Article | Year |
|---|---|
Pathophysiological role of osteopontin and angiotensin II in atherosclerosis.
Topics: Angiotensin II; Animals; Atherosclerosis; Humans; Immunologic Factors; Models, Cardiovascular; Models, Immunological; Osteopontin; Vasculitis | 2016 |
Role of the renin-angiotensin system in vascular inflammation.
Topics: Aldosterone; Angiotensin II; Animals; Capillary Permeability; Chemokine CCL2; Humans; Hypertension; NF-kappa B; Oxidative Stress; Renin-Angiotensin System; Vascular Cell Adhesion Molecule-1; Vasculitis | 2008 |
Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice.
Topics: Adventitia; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Chemokine CCL2; Disease Models, Animal; Female; Fibroblasts; Humans; Hyperhomocysteinemia; Incidence; Interleukin-6; Male; Mice; Mice, Mutant Strains; Middle Aged; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species; Risk Factors; Signal Transduction; Smad2 Protein; Smad3 Protein; Vasculitis; Vasoconstrictor Agents | 2012 |
Vascular actions of aldosterone.
Topics: Adipocytes; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Vessels; Cardiovascular Diseases; Endothelin A Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Hypertrophy; Metabolic Syndrome; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Muscle, Smooth, Vascular; Oxidative Stress; Receptor, Endothelin A; Receptors, Mineralocorticoid; Renin-Angiotensin System; Signal Transduction; Sodium; Vasculitis; Vasoconstriction | 2013 |
Angiotensin II and endothelin induce inflammation and thereby promote hypertension-induced end-organ damage.
Topics: Angiotensin II; Animals; Endothelin-1; Gene Expression Regulation; Humans; Hypertension; NF-kappa B; Vasculitis | 2003 |
Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Calcium Signaling; Humans; Macrophages; Mice; Monocytes; NADPH Oxidases; Oxidative Stress; Phospholipases A; Phosphorylation; Protein Kinase C; Protein Processing, Post-Translational; Superoxides; Vasculitis | 2004 |
Aldosterone-induced organ damage: plasma aldosterone level and inappropriate salt status.
Topics: Aldosterone; Angiotensin II; Animals; Cardiomyopathies; Fibrosis; Humans; Mice; Mice, Transgenic; Receptors, Mineralocorticoid; Renin-Angiotensin System; Sodium Chloride, Dietary; Sodium-Hydrogen Exchangers; Vasculitis | 2004 |
Targets for vascular protection after acute ischemic stroke.
Topics: Acute Disease; Angiopoietins; Angiotensin II; Antioxidants; Apoptosis; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Cerebral Arteries; Cerebral Hemorrhage; Chronic Disease; Endothelin-1; Endothelium, Vascular; Humans; Inflammation Mediators; Matrix Metalloproteinases; Neuroprotective Agents; Neutrophils; Oxidative Stress; Reactive Oxygen Species; Vascular Endothelial Growth Factor A; Vasculitis | 2004 |
The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases.
Topics: Angiotensin II; Animals; Cardiovascular Diseases; Humans; NF-kappa B; Renin-Angiotensin System; Vasculitis | 2007 |
Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.
Topics: Aldosterone; Angiotensin II; Cell Adhesion Molecules; Cytokines; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Progression; Humans; Hypertension; NF-kappa B; Renin-Angiotensin System; Vasculitis | 2007 |
Angiotensin-induced inflammation and vascular injury.
Topics: Angiotensin II; Animals; Humans; Renin-Angiotensin System; Risk Assessment; Sensitivity and Specificity; Vascular Diseases; Vasculitis | 2001 |
1 trial(s) available for angiotensin ii and Angiitis
| Article | Year |
|---|---|
Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Chymases; Combined Modality Therapy; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Cytokines; Female; Gene Expression Profiling; Humans; Male; Microcirculation; Middle Aged; Mitral Valve Stenosis; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Preoperative Care; Ramipril; Renin-Angiotensin System; RNA, Messenger; Serine Endopeptidases; Tetrazoles; Valine; Valsartan; Vasculitis | 2004 |
52 other study(ies) available for angiotensin ii and Angiitis
| Article | Year |
|---|---|
Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Disease Models, Animal; Endothelial Cells; Heart Failure; Leukocyte Rolling; Macrophages; Male; Mice, Inbred C57BL; Monocytes; Muramidase; Myeloid Cells; Myocardial Infarction; NADPH Oxidase 2; Oxidative Stress; Receptor, Angiotensin, Type 1; Signal Transduction; Telmisartan; Vasculitis | 2021 |
Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus.
Topics: Aged; Albuminuria; Angiotensin II; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Early Diagnosis; Endothelium, Vascular; Female; Hospitals, University; Humans; Insulin Resistance; Male; Microvessels; Middle Aged; Outpatient Clinics, Hospital; Prediabetic State; Republic of Korea; Risk Factors; Up-Regulation; Vasculitis | 2017 |
Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis.
Topics: Angiotensin II; Animals; Atherosclerosis; Disease Models, Animal; Inflammation; Leukocytes; Mice; Mice, Knockout; Receptors, LDL; Rho Guanine Nucleotide Exchange Factors; Vasculitis | 2017 |
HDAC4 regulates vascular inflammation via activation of autophagy.
Topics: Acetylation; Angiotensin II; Animals; Autophagy; Cells, Cultured; Disease Models, Animal; Forkhead Box Protein O3; Histone Deacetylases; Male; Mice, Inbred C57BL; Microtubule-Associated Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasculitis | 2018 |
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling.
Topics: Angiotensin II; Animals; Blood Cells; Endothelial Cells; Glycolipids; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Lipopolysaccharides; Lipoproteins, LDL; Mice; Mice, Knockout, ApoE; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; RAW 264.7 Cells; Signal Transduction; THP-1 Cells; Toll-Like Receptor 4; Vasculitis | 2018 |
Peroxisome proliferator-activated receptor γ, coactivator 1α deletion induces angiotensin II-associated vascular dysfunction by increasing mitochondrial oxidative stress and vascular inflammation.
Topics: Angiotensin II; Animals; Apoptosis; Cellular Senescence; Endothelium, Vascular; Mice; Mice, Knockout; Mitochondria; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reactive Oxygen Species; Trans-Activators; Transcription Factors; Vasculitis; Vasoconstrictor Agents | 2013 |
Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation.
Topics: Adult; Angiotensin II; Arm; Cytokines; Endothelial Cells; Endothelium, Vascular; Female; Healthy Volunteers; Heart Failure; Humans; Hyperemia; Male; Neuropeptides; Neurotransmitter Agents; RNA, Messenger; Vascular Cell Adhesion Molecule-1; Vasculitis | 2014 |
Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase.
Topics: Adoptive Transfer; Angiotensin II; Animals; Aortic Diseases; CD4 Antigens; CD8 Antigens; Cells, Cultured; Collagen; Disease Models, Animal; Elastin; Fibroblasts; Homeodomain Proteins; Hypertension; Inflammation; Interleukin-17; Male; Mice; Mice, Knockout; p38 Mitogen-Activated Protein Kinases; Stress, Mechanical; T-Lymphocytes; Vascular Stiffness; Vasculitis; Vasoconstrictor Agents | 2014 |
Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice.
Topics: Angiotensin II; Animals; Aorta; Epigenesis, Genetic; Gene Expression; Hypertension; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Reactive Oxygen Species; Sirtuin 1; Vasculitis | 2014 |
AMPK Suppresses Vascular Inflammation In Vivo by Inhibiting Signal Transducer and Activator of Transcription-1.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Cells, Cultured; Dual Specificity Phosphatase 1; Enzyme Activation; Humans; Interferon-gamma; MAP Kinase Signaling System; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Phosphorylation; Protein Processing, Post-Translational; Random Allocation; Recombinant Proteins; RNA Interference; STAT1 Transcription Factor; Vasculitis | 2015 |
Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.
Topics: Aneurysm, Ruptured; Angiotensin II; Anilides; Animals; Cerebral Arteries; Endothelium, Vascular; Gene Expression Regulation; Genes, Dominant; Hypertension; Inflammation Mediators; Intracranial Aneurysm; Mice; Mice, Transgenic; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; Organ Specificity; Pancreatic Elastase; Pioglitazone; PPAR gamma; Subarachnoid Hemorrhage; Thiazolidinediones; Up-Regulation; Vasculitis | 2015 |
Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension.
Topics: Angiotensin II; Animals; Chemokine CCL5; Female; Gene Expression Regulation; Humans; Hypertension; Interferon-gamma; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Signal Transduction; T-Lymphocytes; Vasculitis | 2016 |
Synergistic effect of atorvastatin and Cyanidin-3-glucoside on angiotensin II-induced inflammation in vascular smooth muscle cells.
Topics: Angiotensin II; Anthocyanins; Anti-Inflammatory Agents; Atherosclerosis; Atorvastatin; Cell Proliferation; Cells, Cultured; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Induction; Glucosides; Humans; Intercellular Adhesion Molecule-1; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Nitric Oxide Synthase Type II; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Vascular Cell Adhesion Molecule-1; Vasculitis | 2016 |
Assessment of Vascular Dysfunction and Inflammation Induced by Angiotensin II in Mice.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blood Pressure; Blood Pressure Monitors; Cell Separation; Drug Administration Schedule; Endothelium, Vascular; Hypertension; Infusion Pumps, Implantable; Macrophages; Mice; Monocytes; Organ Culture Techniques; Osmotic Pressure; Vasculitis | 2017 |
Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Enzyme Activation; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Phosphorylation; Phosphoserine; Platelet-Derived Growth Factor; Point Mutation; PPAR gamma; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcr; Rats; Recombinant Fusion Proteins; RNA, Small Interfering; Tunica Intima; Vasculitis | 2009 |
Attenuation of cuff-induced neointimal formation by overexpression of angiotensin II type 2 receptor-interacting protein 1.
Topics: Angiotensin II; Animals; Arterial Occlusive Diseases; Blood Pressure; Body Weight; Carrier Proteins; Cell Division; Femoral Artery; Gene Expression; Heart; Male; Mice; Mice, Transgenic; Organ Size; Oxidative Stress; Receptor, Angiotensin, Type 2; Superoxides; Tumor Necrosis Factor-alpha; Tumor Suppressor Proteins; Tunica Intima; Vasculitis; Vasoconstrictor Agents | 2009 |
PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Cell Survival; Cells, Cultured; Disease Models, Animal; Gene Expression; Gene Silencing; Hypoglycemic Agents; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Toll-Like Receptor 4; Vasculitis | 2009 |
Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Blood Pressure; Enzyme Inhibitors; Glycosylation; Hypertension; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Reactive Oxygen Species; Superoxides; Time Factors; Vascular Cell Adhesion Molecule-1; Vasculitis | 2010 |
Protection of angiotensin II-induced vascular hypertrophy in vascular smooth muscle-targeted receptor activity-modifying protein 2 transgenic mice.
Topics: Adrenomedullin; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Female; Hypertension; Hypertrophy; Hypotension; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Receptor Activity-Modifying Proteins; Receptors, Adrenomedullin; Receptors, Peptide; Vasculitis | 2009 |
Angiotensin II up-regulates CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesis.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Cell Adhesion; Cell Movement; Chemokine CX3CL1; CX3C Chemokine Receptor 1; Endothelial Cells; Gene Expression Regulation; Humans; Inflammation; Jurkat Cells; Losartan; Monocytes; Receptors, CCR5; Receptors, Chemokine; Receptors, CXCR4; Vasculitis; Vasoconstrictor Agents | 2010 |
Early life stress sensitizes rats to angiotensin II-induced hypertension and vascular inflammation in adult life.
Topics: Angiotensin II; Animals; Animals, Newborn; Baroreflex; Blood Pressure Determination; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Heart Rate; Hypertension; Infusions, Intravenous; Male; Random Allocation; Rats; Rats, Inbred WKY; Reference Values; Renin-Angiotensin System; Stress, Psychological; Vasculitis; Vasoconstrictor Agents | 2010 |
Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension.
Topics: Administration, Oral; Adoptive Transfer; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Genes, T-Cell Receptor alpha; Genes, T-Cell Receptor beta; Homeodomain Proteins; Hydralazine; Hypertension; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Norepinephrine; Receptors, Antigen, T-Cell, alpha-beta; Superoxides; T-Lymphocytes; Third Ventricle; Time Factors; Vasculitis | 2010 |
Inflammation and neurogenic hypertension: a new role for the circumventricular organs?
Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Lymphocyte Activation; Mice; Norepinephrine; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocytes; Third Ventricle; Vasculitis | 2010 |
The counter-regulatory effects of ESE-1 during angiotensin II-mediated vascular inflammation and remodeling.
Topics: Angiotensin II; Animals; Aorta; DNA-Binding Proteins; Endothelium, Vascular; Humans; Hypertension; Male; Mice; Mice, Knockout; Nitric Oxide Synthase Type II; Transcription Factors; Vasculitis | 2010 |
Epithelium-specific ETS-1: a counter-regulatory factor against vascular dysfunction and inflammation.
Topics: Angiotensin II; Animals; Mice; Proto-Oncogene Protein c-ets-1; Transcription Factors; Vasculitis | 2010 |
A novel role for calpain in the endothelial dysfunction induced by activation of angiotensin II type 1 receptor signaling.
Topics: Angiotensin II; Animals; Calpain; Down-Regulation; Endothelium, Vascular; I-kappa B Proteins; Leukocytes; Mesenteric Arteries; Mice; Mice, Mutant Strains; NF-KappaB Inhibitor alpha; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA Interference; Signal Transduction; Vasculitis; Vasoconstrictor Agents | 2011 |
Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction.
Topics: Angiotensin II; Animals; CD11b Antigen; Endothelium, Vascular; Gene Expression; Hypertension; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Monocytes; Muramidase; Muscle, Smooth, Vascular; Neutrophils; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Receptors, Chemokine; Respiratory Burst; Vasculitis; Vasoconstrictor Agents | 2011 |
Interleukin-5 is a potential mediator of angiotensin II-induced aneurysm formation in apolipoprotein E knockout mice.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Cells, Cultured; Interleukin-10; Interleukin-5; Macrophages, Peritoneal; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Th1 Cells; Th2 Cells; Vasculitis; Vasoconstrictor Agents | 2012 |
Endothelial Gab1 deletion accelerates angiotensin II-dependent vascular inflammation and atherosclerosis in apolipoprotein E knockout mice.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Down-Regulation; Female; Gene Deletion; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Mice; Mice, Knockout; Phosphoproteins; Vasculitis | 2012 |
The versatile role of Gab1 in the circulatory system.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Female; Gene Deletion; Male; Phosphoproteins; Vasculitis | 2012 |
Impact of ACE2 deficiency and oxidative stress on cerebrovascular function with aging.
Topics: Acetylcholine; Aging; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Disease Models, Animal; Endothelium, Vascular; Male; Mice; Mice, Knockout; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; RNA, Messenger; Vasculitis; Vasodilation; Vasodilator Agents | 2012 |
Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Blood Platelets; Blood Pressure Determination; Clopidogrel; Cytokines; Immunoenzyme Techniques; Inflammation; Macrophages, Peritoneal; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Receptors, Purinergic P2Y12; Ticlopidine; Vasculitis; Vasoconstrictor Agents | 2012 |
Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Body Weight; Coronary Disease; Coronary Vessels; Corticosterone; Cyclooxygenase 2; Diuresis; Drinking; Eating; Eplerenone; Heart; Hypertension; Isoenzymes; Macrophages; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Necrosis; Organ Size; Osteopontin; Potassium; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Renin; Sialoglycoproteins; Sodium; Sodium Chloride; Spironolactone; Vasculitis | 2002 |
NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy.
Topics: Aldehydes; Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Chemotaxis, Leukocyte; Enzyme Inhibitors; Gene Expression Regulation; Glycoproteins; Hypertrophy; Intercellular Adhesion Molecule-1; Macrophages; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Single-Blind Method; Tunica Intima; Tunica Media; Vasculitis | 2003 |
Inflammation and vascular hypertrophy induced by angiotensin II: role of NADPH oxidase-derived reactive oxygen species independently of blood pressure elevation?
Topics: Angiotensin II; Animals; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Glycoproteins; Humans; Hypertrophy; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Protein Subunits; Rats; Reactive Oxygen Species; Superoxides; Vasculitis | 2003 |
Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation.
Topics: Angiotensin II; Animals; Calcineurin; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomyopathy, Hypertrophic; Cells, Cultured; Chemokine CCL2; Cyclosporine; Femoral Artery; Gene Expression Regulation; Humans; Hyperplasia; Imidazoles; Macrophages; MAP Kinase Kinase 6; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Promoter Regions, Genetic; Protein Biosynthesis; Proteins; Pyridines; Rats; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction; Tetrazoles; Transcription, Genetic; Tunica Intima; Valine; Valsartan; Vasculitis | 2004 |
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease.
Topics: Acrylates; Angiotensin II; Animals; Antihypertensive Agents; Chemokine CCL2; Down-Regulation; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Immunohistochemistry; Macrophages; Myocardial Contraction; Myocardium; Rats; Rats, Inbred SHR; RNA, Messenger; Thiophenes; Ultrasonography; Vasculitis | 2004 |
Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Cell Division; Chemokine CCL2; Coronary Vessels; DNA-Binding Proteins; Extracellular Matrix Proteins; Gene Expression Profiling; Genetic Therapy; Hypertrophy; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred C57BL; Myosin Heavy Chains; Natriuretic Peptide, Brain; Nonmuscle Myosin Type IIB; Nuclear Proteins; Olmesartan Medoxomil; Receptors, CCR2; Receptors, Chemokine; Recombinant Fusion Proteins; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Media; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vasculitis; Ventricular Remodeling | 2004 |
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Coronary Artery Disease; Fibrosis; Hypercholesterolemia; Hypertension, Renovascular; Ligation; Mice; Mice, Knockout; Nephrectomy; Renal Artery; Renin; Renin-Angiotensin System; Rupture, Spontaneous; Th1 Cells; Th2 Cells; Vasculitis | 2004 |
Angiotensin II-mediated vascular inflammation: the balance between vascular endothelial growth factor and angiopoietins.
Topics: Angiopoietins; Angiotensin II; Humans; Vascular Endothelial Growth Factors; Vasculitis | 2005 |
Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm; Apolipoproteins E; Arteriosclerosis; Cell Adhesion Molecules; Chemokines; Enalapril; Endothelium; Gene Expression; Male; Mice; Mice, Knockout; PPAR alpha; PPAR gamma; RNA, Messenger; Up-Regulation; Vasculitis | 2005 |
A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: An IkappaB-independent, RSK-mediated phosphorylation of p65.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Male; MAP Kinase Kinase 1; Muscle, Smooth, Vascular; Phosphorylation; ras Proteins; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 90-kDa; RNA, Small Interfering; Signal Transduction; Transcription Factor RelA; Vasculitis; Vasoconstrictor Agents | 2005 |
Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury.
Topics: Angiotensin II; Animals; Aorta; Endothelium, Vascular; Inflammation Mediators; Macrophage Colony-Stimulating Factor; Macrophages; Mesenteric Arteries; Mice; Mice, Inbred Strains; Mice, Mutant Strains; NADPH Oxidases; Osteopetrosis; Oxidative Stress; Phenotype; Reactive Oxygen Species; Vascular Resistance; Vasculitis; Vasoconstrictor Agents | 2005 |
Heme oxygenase-1 in vascular smooth muscle cells counteracts cardiovascular damage induced by angiotensin II.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin II; Animals; Blood Pressure; Cardiovascular System; Coronary Vessels; Deoxyguanosine; Dose-Response Relationship, Drug; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hyperplasia; Isoprostanes; Membrane Proteins; Mice; Mice, Transgenic; Muscle, Smooth, Vascular; Myocardium; Myocytes, Cardiac; Myocytes, Smooth Muscle; Oxidative Stress; Sodium Chloride, Dietary; Transduction, Genetic; Tunica Intima; Vasculitis | 2005 |
Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization.
Topics: Angiotensin II; Animals; Capillaries; Hindlimb; Ischemia; Male; Mice; Mice, Inbred C57BL; Naphthalenes; Neovascularization, Physiologic; Propionates; Receptors, Thromboxane A2, Prostaglandin H2; Signal Transduction; Thromboxane A2; Thromboxane B2; Vasculitis; Vasoconstrictor Agents | 2006 |
Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Volume; Hypertension, Renal; Lymphocytes; Macrophages; Male; Microcirculation; Nephritis; Rats; Rats, Sprague-Dawley; Renal Circulation; Sodium Chloride, Dietary; Tetrazoles; Vasculitis; Vasoconstrictor Agents | 2006 |
Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II.
Topics: Amidohydrolases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arginine; Cell Adhesion; Cells, Cultured; Culture Media, Conditioned; Endothelial Cells; Endothelium, Vascular; Gene Expression Regulation; Humans; Interleukin-8; Losartan; Monocytes; NF-kappa B; Nitrates; Nitric Oxide; Nitrites; Protein-Arginine N-Methyltransferases; Reactive Oxygen Species; Receptors, Interleukin-8B; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Umbilical Veins; Vasculitis; Vasodilation | 2007 |
Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species.
Topics: Angiotensin II; Animals; Antioxidants; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Femoral Artery; Gene Transfer Techniques; I-kappa B Proteins; Macrophages; Male; Muscle, Smooth, Vascular; NF-kappa B; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Promoter Regions, Genetic; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Tunica Intima; Up-Regulation; Vasculitis | 2008 |
Angiotensin induces inflammatory activation of human vascular smooth muscle cells.
Topics: Angiotensin II; Arteriosclerosis; Cells, Cultured; Humans; Interleukin-6; Muscle, Smooth, Vascular; NF-kappa B; Peptidyl-Dipeptidase A; Pyrrolidines; Receptors, Angiotensin; RNA, Messenger; Thiocarbamates; Vasculitis | 1999 |
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Chemokine CCL2; Coronary Circulation; Coronary Disease; DNA; Gene Expression; Humans; Hypertension; Intercellular Adhesion Molecule-1; Kidney Diseases; Male; NF-kappa B; Nitric Oxide Synthase; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Thiocarbamates; Transcription Factor AP-1; Vasculitis | 2000 |
CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Biomarkers; Cell Movement; Endothelium, Vascular; Hypertension; Hypertrophy; Macrophages; Mice; Mice, Inbred C57BL; Receptor, Macrophage Colony-Stimulating Factor; Receptors, CCR2; Receptors, Chemokine; Vasculitis; Vasoconstrictor Agents | 2000 |
Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart; Losartan; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasculitis | 2000 |